Hot Corner Insider Articles

I’m really grateful for the path I took in getting where I am today.

I wasn’t always hanging out on an island trading and covering the stock market.

I put in my time. 

I started my career in the Big 4, auditing some of the largest financial institutions in the world.

I spent long nights ticking and tying financial statements and testing derivative valuations for companies like Morgan Stanley and Interactive Brokers.

I know the strangest things about these companies' fundamentals and their history. I made friends and memories I’ll never forget. I was in the room for some historic market events. When I think back on some chapters of my early adult life, they were literally set in these offices. 

But none of the non-public information I learned at these places back in the day is relevant or material now. I have an insider's understanding of these businesses, but no special information about them. 

And I don’t need it. I’m a long-term bull on a lot of these companies simply because of the people who run them. Some have been great mentors over the...

Today’s top moves come via two significant 13G filings.

Point72 Asset Management boosted its stake in Syndax Pharmaceuticals $SNDX from 3.25% to 5.00%.

This increase signals growing confidence in the company’s prospects from one of the most high-profile hedge funds in the market.

Here’s The Hot Corner, with data from January 23, 2025:

Dimensional Fund Advisors disclosed an initial 5.30% position in Academy Sports and Outdoors $ASO. 

A 13G is a passive stake filing that reveals when an investor takes a large position (over 5%) in a company.

It’s often a sign they see solid potential in the stock and are placing a bet on its future growth.

Let’s kick off with UnitedHealth Group $UNH, where Director Timothy P. Flynn made waves by purchasing 1,000 shares, a buy worth $511,575. 

That’s a confident signal from inside one of the healthcare giants.

Here’s The Hot Corner, with data from January 22, 2025:

Meanwhile, over at Home BancShares $HOMB, Chairman, CEO, and Co-Founder John W. Allison put his money where his mouth is, snapping up 10,000 shares. 

That’s a bold vote of confidence from the man who built the bank from the ground up.

The stock has carved out a massive base for the last eight years. Price is pressing against the top of the range as buyers work on absorbing all the overhead supply at this resistance zone:

If we get a decisive breakout above 30, the path of least resistance will switch higher.

Thanks to everyone who joined us for today's Hot Corner Insider Weekly Strategy Session.

Today’s standout insider activity comes from Kevin Johnson, a director at Goldman Sachs Group $GS.

Johnson made a bold statement of confidence by purchasing 2,400 GS shares, a total investment of $1.4 million. 

Here’s The Hot Corner, with data from January 21, 2025:

EcoR1 Capital also made a significant move, filing a Form 4 for Zymeworks Inc $ZYME that shows a purchase of $1,963,538.

Finally, Valinor Management filed a 13D for Nextdecade Corp $NEXT, reporting an increase in its ownership stake from 5.28% to 5.70%.

Rep. Nancy Pelosi, no stranger to headline-grabbing stock moves, is back in the spotlight with her latest Periodic Transaction Report—and it’s a big one.

The former Speaker of the House is making bold plays in some of the hottest sectors, doubling down on AI, and other growth trends, while dumping shares in Apple.

Here’s an update of her filing from Friday:

Pelosi recently sold 31,600 shares of Apple $AAPL, with a transaction value of roughly $8 million.

While she has been bullish on Apple in the past, this marks a notable reduction in her exposure. We know that she acquired about half the shares she just sold via call options back in May 2022. She made more than 80% on them.

So, Nancy is bearish Apple. But, we don’t follow her for her insider sales, we follow the Pelosi portfolio because it has been early to some of the best trends in growth investing. The Pelosi’s were early to NVDA. She has...

Rep. Nancy Pelosi is back on our list after filing a Periodic Transaction Report detailing transactions in multiple stocks.

The former Speaker of the House reported the following moves:

Nvidia $NVDA:

• Exercised $500K-$1M in call options with $12 strike, expiring 12/20/24.
• Bought $250K-$500K in call options with $80 strike, expiring 1/16/26.

Palo Alto Networks $PANW:

• Purchased $1M-$5M in call options with $100 strike, expiring 12/20/24.

Alphabet Inc $GOOGL:

• Purchased $250K-$500K in call options with $150 strike, expiring 1/16/26.

Amazon.com Inc $AMZN:

• Purchased $250K-$500K in call options with $150 strike, expiring 1/16/26.

Tempus AI Inc $TEM:

• Purchased $50K-$100K in call options with $20 strike, expiring 1/16/26.

Today’s standout insider activity comes from Neogen Corporation $NEOG.

Both the CEO and CFO filed Form 4s, reporting significant purchases of their company’s stock.

When the company’s top executives—the strategic decision-maker (CEO) and the financial steward (CFO)—make simultaneous moves, it’s a signal worth noting.

These leaders have valuable insights into the company’s numbers, projections, and future direction.

Here’s The Hot Corner, with data from January 16, 2025:

Control Empresarial De Capitales SA revealed an additional $2.8 million investment in PBF Energy, increasing its ownership stake to an impressive 25.17%.

Last but not least, Broadwood Partners disclosed the acquisition of 29,376 shares of STAAR Surgical Company $STAA, valued at $630,838.

EcoR1 Capital, a biotech-focused hedge fund, made waves today with a substantial Form 4 filing.

The fund reported a purchase of $2,278,811 worth of Zymeworks $ZYME, increasing its ownership stake to 22.61%.

It’s worth noting that EcoR1 has a strong track record of identifying winners in the biotech space, often making concentrated bets on companies with transformative pipelines or innovative therapies.

Here’s The Hot Corner, with data from January 15, 2025:

On another note, Phillip Frost, CEO of OPKO Health Inc $OPK, disclosed the acquisition of 500,000 shares, continuing a pattern of insider buying.

Thanks to everyone who joined us for today's Hot Corner Insider Weekly Strategy Session.

Today’s standout transaction is a Form 4 filing by Director Robert Niblock, who made a bold statement with the purchase of 3,000 Lamb Weston Holdings Inc $LW shares, for a cost of $182,818.

Here’s The Hot Corner, with data from January 14, 2025:

Meanwhile, Senator John Boozman of Arkansas has also caught our attention, reporting a buy in an amount between $1,000 and $15,000 in Applied Materials $AMAT, a key player in the semiconductor equipment space.

I like to lean on bellwethers when I’m on the fence about a theme or area of the market.

The term bellwether comes from agrarian times. It was used to describe the sheep that leads the flock. They would put a bell around its neck.

Stock market bellwethers are similar.

To me, a bellwether is a stock that represents a broader group of stocks. These companies usually dominate their industries. Many times, they are secular leaders also.

We’re talking about JP Morgan in the world of financials. Caterpillar for industrials. Amazon and Walmart for the consumer. You get it.

And bellwethers are also vehicles. They are among the many alternatives at our disposal when we choose to express a thesis on something. They are usually some of the most liquid as well.

I use them when I am trying to keep it simple.

I am always thinking about what vehicle is best....